Stay updated on Bemcentinib in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Bemcentinib in AML/MDS Clinical Trial page.

Latest updates to the Bemcentinib in AML/MDS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows a new revision label 'Revision: v3.5.4', indicating a minor update to the page’s version, while the previous revision label 'v3.5.3' was removed.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page’s release/build revision indicator has been updated from `v3.5.2` to `v3.5.3` at the bottom of the ClinicalTrials.gov page.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check86 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to study details or page layout.SummaryDifference0.0%

- Check107 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no substantive changes to the study details, eligibility criteria, locations, or outcome measures were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Bemcentinib in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bemcentinib in AML/MDS Clinical Trial page.